Correlation Between Virax Biolabs and Immunocore Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Immunocore Holdings, you can compare the effects of market volatilities on Virax Biolabs and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Immunocore Holdings.

Diversification Opportunities for Virax Biolabs and Immunocore Holdings

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Virax and Immunocore is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Immunocore Holdings go up and down completely randomly.

Pair Corralation between Virax Biolabs and Immunocore Holdings

Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 6.33 times more return on investment than Immunocore Holdings. However, Virax Biolabs is 6.33 times more volatile than Immunocore Holdings. It trades about 0.08 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.14 per unit of risk. If you would invest  96.00  in Virax Biolabs Group on August 27, 2024 and sell it today you would earn a total of  105.00  from holding Virax Biolabs Group or generate 109.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Virax Biolabs Group  vs.  Immunocore Holdings

 Performance 
       Timeline  
Virax Biolabs Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Immunocore Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Virax Biolabs and Immunocore Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virax Biolabs and Immunocore Holdings

The main advantage of trading using opposite Virax Biolabs and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.
The idea behind Virax Biolabs Group and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges